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ABSTRACT 
 
The ocean is abundant in organisms beneficial to living beings, including cyanobacteria that 
are widely studied for their bioactive compounds. This research was conducted to observe the 
compounds and concomitant cytotoxic activities of cyanobacteria in Udar Island waters, Sabah, 
Malaysia, against cancer cells. The samples were identified by the 16S DNA method, and a 
phylogenetic tree was built to check similarities in the genus. The samples were extracted using 
ethyl acetate and butanol. Afterward, the compounds were determined by Liquid Chromatography-
Mass Spectrometry (LCMS), while the cytotoxicity activities were examined by the MTT assay. 
Several known compounds in ethyl acetate crude extract, such as several types of Apratoxins, and 
possible new compounds were observed. The compounds examined were mainly peptide. The 
crude ethyl acetate extracts of Moorea sp. in Udar Island waters were found to contain cytotoxic 
compounds, with the IC50 value of 0.072 µg/mL against the MCF-7 breast cancer cell lines, that 
were more potent compared to the butanol crude extract, whose IC50 was 2.031 µg/mL. Further 
isolation and cytotoxic tests are necessary to confirm which compounds are responsible as 
cytotoxic agents. This finding provides an opportunity for the discovery of anticancer compounds 
from marine cyanobacteria. 
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INTRODUCTION  
Cancer is one of the leading causes of death in the world with a continuously increasing 
number of cancer patients from year to year. Several types of cancer drugs are available for use, but 
some have side effects that are not well tolerated (Monsuez et al., 2010). Many scientists have been 
trying to discover or invent some other substances for cancer treatment. In the last few decades, 
numerous cancer drugs have been developed from natural ingredients, providing alternatives that 
expectedly give a better response (Gordaliza, 2007).  
More than two thirds (70%) of the Earth’s surface is covered with water, creating a large 
habitat for marine organisms and a prolific source of organisms with high biological and chemical 
diversities. A countless number of marine organisms and marine biota are known to provide 
benefits to life. Marine organisms produce some specific chemical compounds to adapt to their 
environments and for their survival. For this reason, the compounds from marine natural products 
have been considered as potential sources of therapeutic agents to treat various diseases, including 
cancer (Newman and Cragg, 2016). Cytotoxic effects have been observed in, among others, marine 
sponges and marine tunicates (Reyes et al., 2008; Susilowati et al., 2019). Several derivatives even 
have been used clinically as medicine, e.g., trabectedin isolated from the Caribbean tunicate for the 
treatment of advance soft tissue sarcoma (D’Incalci et al., 2014) and ziconotide and eribulin 
mesylate derived from the substances isolated from marine organisms (De Negri et al., 2012; 
Gomes et al., 2016). An example of organisms that are diverse in chemical compounds is 
cyanobacteria (Uzair et al., 2012). Apratoxin A collected from marine cyanobacteria has been 
investigated for its bioactivities, for example, antibacterial, anticancer, antiparasitic, and antiviral 
(Luesch et al., 2001). Several bioactive compounds are very likely to be found in Cyanobacteria, 
especially from uncharted places in Malaysian waters. The Sarawak and Sabah states have a long 
coastline with high marine biodiversity that provides opportunities for researchers to explore more 
organisms and new beneficial compounds. This study was designed to identify the compounds 
contained in cyanobacteria living in unexplored Malaysian waters and observe their cytotoxic 
properties.    
 
MATERIALS AND METHODS  
Materials 
The study used the QIAquick Poly Chain Reaction (PCR) purification kit (Diagen, 
Düsseldorf, Germany) to identify the sample  and commercially synthesized primers (Invitrogen
TM
). 
The PCR product was then checked with the ABI PRISM 3100 Sequence Detection System in the 
3130xl Genetic Analyzer (Hitachi, Japan). The MCF-7 breast cancer cell line was used to test the 
cytotoxicity of the sample. Cisplatin (Sigma Aldrich) was used as the positive control. 
Methods 
Sample collection 
The fresh mat-forming cyanobacteria  was  sampled from Udar Island, Malaysia, at the depth 
between 7 and 15 m (N6º4’44’’, E116º5’10”) in March 2015. A small portion of the fresh sample 
was preserved in RNAlater® stabilization solution (Ambion, USA) for identification, while another 
portion of them was soaked in methanol for further extraction. Figure 1 is the underwater 
photograph of the cyanobacteria sample.  
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Figure 1. The underwater photograph of the research samples (Courtesy of Prof. Tatsufumi Okino) 
 
Sample identification 
The cyanobacteria sample  was  identified by molecular phylogenetic studies based on 16S 
rRNA gene or 16S DNA sequence data with the method elaborated in Nübel et al. (1997). Firstly, 
the extraction solution was prepared to extract the DNAs. Secondly, the Poly Chain Reaction 
(PCR) was used to obtain the DNA sequence. The 16S DNA gene sequencing analysis has been 
reported as one of the methods suitable for the molecular genomic identification and phylogenetic 
classification of cyanobacteria (Wilmotte, 1994). 
Extraction and isolation 
The methanol crude extract was  partitioned with ethyl acetate (EtOAc), butanol (BuOH), 
and water (H2O) as part of the identification of lipophilic and hydrophilic compounds. The 
partitioned crude extracts were then checked by Liquid Chromatography-Mass Spectrometry 
(LCMS) at a concentration of 100µg/mL. This concentration was obtained by diluting the extracts 
with filtered ethanol, while the water fraction was diluted with water. 
Compound identification 
The chemical profiles of the sample were observed by the Electrospray Ionization (ESI) 
Liquid Chromatography-Mass Spectrometry (LCMS) with the Agilent 1100 Series HPLC system 
coupled to mass spectrometry (Brucker Daltonic, Germany) with the 2 x 150 mm Cadenza C18 
column (USA). Eluent A was water added with 0.1% formic acid, and eluent B was acetonitrile 
(MeCN) added with 0.1% formic acid at a flow rate of 0.2 mL/min. The elution gradient started 
with 50% of eluent B and increased to 80% in 15 minutes, then the isocratic condition of the 80% 
eluent B was allowed to stand for 15 minutes before going back to the initial condition within 0.1 s. 
Cytotoxicity assay 
The sampled cyanobacteria was screened for cytotoxic activities by an in vitro MTT assay 
(Challouf et al., 2011; Li and Song, 2007). The MCF-7 cells were treated with the samples in 
different concentrations and incubated at 37°C with 5% CO2 for 72 hours. The yellow MTT reagent 
was reduced to formazan (purple) by the metabolically active cells in the mitochondrial of the 
living cell. The formazan can be dissolved in DMSO (dimethyl-sulfoxide) organic solvent and has 
the optical density (OD) measurable at 570 nm. 
All of the experiments were conducted in Environmental Science Development Laboratory 
of Hokkaido University, Japan. 
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Data Analysis 
Sample identification 
The phylogenetic analysis was conducted in MEGA 6 (Molecular Evolutionary Genetics 
Analysis version 6) by constructing a phylogenetic tree from the DNA sequence data using an 
optimality criterion, namely, maximum likelihood. Bootstrapping was performed with 1000 
replicates. 
 
Compound identification 
The LCMS yielded the mass of every identified compound that was later checked against the 
MarinLit database.  
 
Cytotoxicity 
The MTT assay results of the crude extracts were compared to Cisplatin as the positive 
control. The cytotoxicity was determined from the ability of the compound to kill the cell lines, 
while the percent toxicity was measured by comparing the absorbances of the samples and blank at 
OD 570 nm. The ethyl acetate and butanol crude extracts were tested for their cytotoxic activities at 
concentrations of 0.1, 1, 10, and 100 µg/mL. The IC50 values, which represent the ability of the 
extracts to remove 50% of the cell lines, were determined based on the graph of percent 
cytotoxicity against various concentrations of the crude extracts.  
 
RESULTS AND DISCUSSION  
Sample identification 
The cyanobacteria sample collected from Udar Island was identified as cyanobacteria 
belonging to the genus Moorea sp. Based on the phylogenetic tree (Figure 2), these samples were 
close to Moorea sp and Moorea bouillonii. 
 
 
 
Figure 2. The phylogenetic tree of the marine cyanobacteria collected from Udar Island (M1504) 
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According to Lopez et al. (2017), the marine cyanobacteria collected from Mantanani Island 
in Sabah, Malaysia, have been identified as Moorea bouillonii. Udar Island is located 
approximately 28 km from Kota Kinabalu, the capital city of Sabah, while Mantanani Island is 
located much further. Based on the morphology, the sample were mat-forming, which is typical of 
Moorea bouillonii. This finding shows that the marine cyanobacteria collected in the waters of 
Udar Island probably is similar to the ones found in Mantanani Island. However, further DNA 
analysis is still required to confirm the identity. The purity and quality of DNA are crucial in 
obtaining a good gene sequence. 
 
Extraction and isolation 
This step produced three parts of the crude extracts, namely, EtOAc, BuOH, and H2O 
fractions with the respective masses of 330 mg, 110 mg, and 3710 mg. The oily liquid forms were 
observed in the EtOAc dan BuOH fractions, and the salts were observed in the water fraction. The 
EtOAc and BuOH fractions were greenish, while the water fraction was light brownish.  
Identified Compounds  
Several secondary metabolites were observed from the LCMS result of the ethyl acetate 
fraction, as displayed in Figure 3. The LCMS results of the butanol and water fractions did not give 
a good chemical pattern, and, therefore, they are not discussed further. Based on the mass spectra 
presented in Table I, the ethyl acetate fraction was found to contain several known compounds, 
such as Apratoxins, Columbamide D, Wewakazole, and Laingolide B, and a possible new 
compound. Cyanobacteria in the genus Moorea have been studied as a rich source of novel 
bioactive compounds (Engene et al., 2012). The LCMS revealed that the Moorea sp. collected from 
Udar Island is rich in secondary metabolites, which are mainly peptides.  
 
 
Figure 3. The chromatogram of the ethyl acetate fraction of marine cyanobacteria collected from 
Udar Island, as produced by the LCMS 
The observed mass of Apratoxin A from the sample was similar to the Moorea bouilonii 
samples collected from Guam, Palau, Papua New Guinea, and Malaysia (Lopez et al., 2017; 
Matthew et al., 2010; Tan et al., 2013). In other words, Apratoxin A has been frequently observed 
from Moorea bouilonii samples. The previous research of Moorea bouilonii in Mantanani Island 
confirms the presence of Apratoxin A, Apratoxin C, Wewakazole, and Columbamide, specifically 
Columbamide D and Columbamide E (Lopez et al., 2017). In the present study, these compounds 
were also observed, except for Columbamide E. This finding reveals how different environments 
may affect the secondary metabolites of the organisms. The cyanobacteria collected from Udar 
Island contain a possible new compound (number 6 in Table I) based on the observation of the 
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exact mass on the MarinLit database. Further isolation of the selected possible new compound is 
necessary to confirm its exact identity, preferably through nuclear magnetic resonance (NMR) 
analysis. 
 
Table I. Several known compounds observed by their respective mass that describe the samples of 
marine cyanobacteria collected from Udar Island 
Retention 
time (min) 
Observed 
mass (M+H) 
Compounds Structures 
7 692.3146 
Ulongamide C 
C36H45N5O7S 
 
 
11 1141.5349 
Wewakazole 
C59H72N12O12 
 
 
 
13 722.3627 
Lyngbyapeptin B 
C38H51N5O7S 
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Retention 
time (min) 
Observed 
mass (M+H) 
Compounds Structures 
16.2 737.4464 
Hantupeptin A 
C41H60N4O8 
 
 
 
18.5 826.4841 
Apratoxin C 
 
C44H67N5O8S 
 
 
20 507.3827 
New compound New compound 
20 840.5006 
Apratoxin A 
C45H69N5O8S 
 
22.1 338.2674 
Laingolide A  
C20H35NO3 
or palmyrolide A 
C20H35NO3 
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Retention 
time (min) 
Observed 
mass (M+H) 
Compounds Structures 
 
 
24 452.2709 
Columbamide D 
C23H43Cl2NO3 
 
 
 
 
24 352.2841 
Laingolide B 
C20H32ClNO3 
 
27 378.3005 
Madangolide 
C23H39NO3 
 
 
Cytotoxicity 
Various concentrations of the ethyl acetate and butanol crude extracts were tested against 
MCF-7 breast adenocarcinoma cancer cells. Figure 4 shows the log concentrations on the 
horizontal axis and the percentage of dead cells on the vertical axis. Then, the IC50 values were 
determined by the linear regression. Based on the results, the linearity of the ethyl acetate crude 
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extract (EtOAc) was not acceptable, as evidenced by R
2
 = 0.506. As determined with the linear 
regression equation, the IC50 of the ethyl acetate crude extracts was 0.072 µg/mL. Since the percent 
cytotoxicity from the experiment increased significantly from 0.1 to 1 µg/mL, more testing of 
cytotoxicity between the two concentrations is highly suggested. Compared to Cisplatin, the 
cytotoxicity of the ethyl acetate crude extract was higher. This result was probably due to the 
presence of known Apratoxins (Apratoxin A and Apratoxin C), which are cytotoxic even at the 
nano level (Luesch et al., 2001). 
 
 
 
Figure 4. The MTT assay results of the ethyl acetate (EtOAc) and butanol (BuOH) crude extracts of 
marine cyanobacteria collected from Udar Island against MCF-7 breast cancer cells with 
cisplatin as the positive control 
 
As seen in Table II, the butanol crude extract exhibited adequate cytotoxic activities at the 
concentration of 10 µg/mL upwards. The IC50 value of this extract was 2.031 µg/mL. This finding 
indicates that the ethyl acetate fraction is more potent compared to the butanol fraction.   
 
Table II. The observed cytotoxic activities of the ethyl acetate and butanol crude extracts of marine 
cyanobacteria collected from Udar Island  
Extracts % Cytotoxicity at Concentration IC50 (µg/mL) 
0.1 µg/mL 1 µg/mL 10 µg/mL 100 µg/mL 
Cisplatin 24 61 93 99 0.564 
Ethyl Acetate 31 99.5 95 92 0.072 
Butanol 10 26 93 96 2.031 
 
Further assays must be completed to analyze the target compounds in the ethyl acetate 
fraction. For this reason, the mechanism through which the cytotoxic compounds act must be 
investigated more. However, several compounds have been reported to inhibit cell growth in a 
variety of cancer lines and induce cell death by apoptosis (Costa et al., 2012). 
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CONCLUSION  
Cyanobacteria in the genus Moorea sp. in the waters of Udar Island, Malaysia, contain many 
chemical compounds and a possible new compound in their ethyl acetate fraction, as confirmed by 
the observed mass. Compared to the butanol crude extract, the ethyl acetate crude extract is more 
potent, with the IC50 value of 0.072 µg/mL. Further isolation, purification, and analysis are required 
to clarify the specific compounds. The compounds isolated from Moorea sp. can be a new source 
from marine natural products to develop a new anticancer agent. 
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